No evidence of an association between the APOBEC3B deletion polymorphism and susceptibility to HIV infection and AIDS in Japanese and indian populations

Journal of Infectious Diseases

Volumn 202, Issue 5, 2010, Pages 815-816

  Itaya, Sakiko ^a   Nakajima, Toshiaki ^a   Kaur, Gurvinder ^c   Terunuma, Hiroshi ^b   Ohtani, Hitoshi ^a   Mehra, Narinder ^c   Kimura, Akinori ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b Biotherapy Institute of Japan   (Japan)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3B; HYDROLASE; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOBEC3B GENE; CD4 LYMPHOCYTE COUNT; GENE; GENE DELETION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HEMOPHILIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INDIAN; JAPANESE; LETTER; PRIORITY JOURNAL; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ASIAN CONTINENTAL ANCESTRY GROUP; CYTIDINE DEAMINASE; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; HIV INFECTIONS; HIV-1; HUMANS; INDIA; JAPAN; POLYMORPHISM, GENETIC;

EID: 77955671317     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/655227     Document Type: Letter

References (10)

1. Sheehy AM, Gaddis NC, Choi JD,MalimMH. Isolation of a human gene that inhibits HIV- 1 infection and is suppressed by the viral Vif protein. Nature 2002; 418:646-650.
2. Bishop KN, Holmes RK, Sheehy AM, Davidson NO, Cho SJ, Malim MH. Cytidine deamination of retroviral DNA by diverse APOBEC proteins. Curr Biol 2004; 14:1392-1396.
3. Chiu YL, Greene WC. Multifaceted antiviral actions of APOBEC3 cytidine deaminases. Trends Immunol 2006; 27:291-297.
4. Kidd JM, Newman TL, Tuzun E, Kaul R, Eichler EE. Population stratification of a common APOBEC gene deletion polymorphism. PLoS Genet 2007; 3:e63.
5. An P, Johnson R, Phair J, et al. APOBEC3B deletion and risk of HIV-1 acquisition. J Infect Dis 2009; 200:1054-1058.
6. Nakajima T, Nakayama EE, Kaur G, et al. Impact of novel TRIM5a variants, Gly110Arg and G176del, on the anti-HIV-1 activity and the susceptibility to HIV-1 infection. AIDS 2009; 23:2091-2100.
7. Yu Q, Chen D, König R, Mariani R, Unutmaz D, Landau NR. APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication. J Biol Chem 2004; 279:53379-53386.
8. Romani B, Engelbrecht S, Glashoff RH. Antiviral roles of APOBEC proteins against HIV- 1 and suppression by Vif. Arch Virol 2009; 154:1579-1588.
9. Doehle BP, Schäfer A, Cullen BR. Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif. Virology 2005; 339:281-288.
10. Jarmuz A, Chester A, Bayliss J, et al. An anthropoid- specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics 2002; 79:285-296.